New drug aims to tame rare blood disorder
Disease control
Ongoing
This early-stage study is testing an experimental drug called SLN124 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The trial will first find a safe dose, then compare SLN124 against a placebo to see if it can reduce the need for bloo…
Phase: PHASE1, PHASE2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC